Table 2 In vitro antiproliferative effects of compound 2, ibrutinib and ACP-196 against TMD8 cells

From: Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton’s tyrosine kinase inhibitors

Compd.

Cellular antiproliferative activity (IC50, μM)

2

0.028 ± 0.014

Ibrutinib

0.010 ± 0.005

ACP-196

0.014 ± 0.004